Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

Prostate cancer is the most common cancer among men after skin cancer, according to the American Cancer Society.

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

In this randomized screening trial, the multivariable Stockholm3 test provided greater clinical net benefit and substantially ...

Per 1,000 men screened, the Stockholm3 test detected 31.6 clinically significant prostate cancer cases compared with 25.8 for ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

The nuclear medicine therapy targets prostate-specific membrane antigen (PSMA)-positive cancer cells, delivering radiation directly to tumours while limiting damage to healthy tissue—a shift toward ...

Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that change?

A replication-defective adenoviral HSV-TK vector enables valacyclovir-mediated tumor cytotoxicity, potentiated by radiation-induced DNA damage and local immune priming via capsid antigen release.